MORGAN STANLEY

Position in NAUT — Nautilus Biotechnology, Inc.

CIK 895421 NEW YORK, NY

Position in NAUT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$183,655

-$8,415 QoQ

Shares Held

98,212

+98.4% QoQ

Ownership

0.077%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#33

of 93 holders

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 89% Shared 0% None 11%

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,717,847,278 across 523 Biotechnology names. NAUT ranks #329 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	42,931,597	$2,407,174,637
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,242,139	$1,610,467,694
3	ROIV	Roivant Sciences Ltd.	42,592,905	$1,507,362,901
4	REGN	Regeneron Pharmaceuticals, Inc.	1,397,712	$871,529,332
5	MRNA	Moderna, Inc.	9,538,094	$667,952,718
6	ARGX	Argenx SE	643,123	$596,670,219
7	TECH	BIO-TECHNE Corp	6,374,717	$450,373,747
8	INCY	Incyte Corp	2,948,364	$334,226,536

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$183,655	98,212	+98.4%	Shares	Defined	2026-08-13
2026-03-31	$192,070	49,503	-9.3%	Shares	Defined	2026-05-15
2025-06-30	$39,567	54,577	-68.3%	Shares	Defined	2025-08-15
2025-03-31	$148,228	172,161	-57.7%	Shares	Defined	2025-05-15
2024-03-31	$1,195,374	406,591	-7.8%	Shares	Defined	2024-10-17
2023-12-31	$1,317,889	440,766	+9.4%	Shares	Defined	2024-08-16
2023-09-30	$1,272,877	402,810	-4.6%	Shares	Defined	2023-11-15
2023-06-30	$1,633,440	422,078	+1.9%	Shares	Defined	2023-08-14
2023-03-31	$1,147,282	414,182	+11.5%	Shares	Defined	2023-05-15
2022-12-31	$668,902	371,614	+25.4%	Shares	Defined	2023-02-14
2022-09-30	$628,057	296,255	+598.2%	Shares	Defined	2022-11-14
2021-12-31	$219,791	42,431	+38.0%	Shares	Defined	2022-02-14
2021-09-30	$188,841	30,756	—	Shares	Defined	2021-11-15
No filing history on record for this holder in this stock.